| Identification | Back Directory | [Name]
L-Leucine, L-seryl-L-isoleucyl-L-isoleucylglycyl-L-phenylalanyl-L-α-glutamyl-L-lysyl- | [CAS]
148274-82-2 | [Synonyms]
L-Leucine, L-seryl-L-isoleucyl-L-isoleucylglycyl-L-phenylalanyl-L-α-glutamyl-L-lysyl- | [Molecular Formula]
C43H71N9O12 | [MOL File]
148274-82-2.mol | [Molecular Weight]
906.08 |
| Chemical Properties | Back Directory | [Boiling point ]
1315.0±65.0 °C(Predicted) | [density ]
1.225±0.06 g/cm3(Predicted) | [pka]
3.37±0.10(Predicted) | [Sequence]
Ser-Ile-Ile-Gly-Phe-Glu-Lys-Leu |
| Hazard Information | Back Directory | [Uses]
OVA G4 peptide is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL (257-264). SIINFEKL is routinely used to stimulate ovalbumin-specific T cells and to test new vaccine adjuvants can form a stable hydrogel[1][2]. | [References]
[1] Fran?ois P, et al. Phenotypic model for early T-cell activation displaying sensitivity, specificity, and antagonism. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E888-97. DOI:10.1073/pnas.1300752110
[2] Kamalov M,et al. Ovalbumin Epitope SIINFEKL Self-Assembles into a Supramolecular Hydrogel. Sci Rep. 2019 Feb 25;9(1):2696. DOI:10.1038/s41598-019-39148-8 |
|
|